These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20300896)

  • 41. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of hypromellose particle size effects on drug release from sustained release hydrophilic matrix tablets.
    Mitchell SA; Balwinski KM
    Drug Dev Ind Pharm; 2007 Sep; 33(9):952-8. PubMed ID: 17891581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of cellulose ether polymers on ibuprofen release from matrix tablets.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2005 Aug; 31(7):653-65. PubMed ID: 16207613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of extended release divalproex sodium tablets containing hypdrophobic and hydrophilic matrix.
    Chakraborty S; Pandit JK; Srinatha A
    Curr Drug Deliv; 2009 Jul; 6(3):291-6. PubMed ID: 19604143
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of injection moulding as a pharmaceutical technology to produce matrix tablets.
    Quinten T; De Beer T; Vervaet C; Remon JP
    Eur J Pharm Biopharm; 2009 Jan; 71(1):145-54. PubMed ID: 18511248
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of hydroxypropyl methylcellulose matrix systems as swellable gastro-retentive drug delivery systems (GRDDS).
    Matharu AS; Motto MG; Patel MR; Simonelli AP; Dave RH
    J Pharm Sci; 2011 Jan; 100(1):150-63. PubMed ID: 20572054
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction.
    Hariharan M; Wowchuk C; Nkansah P; Gupta VK
    Drug Dev Ind Pharm; 2004 Jul; 30(6):565-72. PubMed ID: 15285329
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Development and evaluation of sustained-release Compritol® 888 ATO matrix mini-tablets.
    Roberts M; Vellucci D; Mostafa S; Miolane C; Marchaud D
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1068-76. PubMed ID: 22149472
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets.
    Miranda A; Millán M; Caraballo I
    J Pharm Sci; 2007 Oct; 96(10):2746-56. PubMed ID: 17506514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and evaluation of gastroretentive floating tablets of acyclovir.
    Garg R; Gupta GD
    Curr Drug Deliv; 2009 Oct; 6(5):437-43. PubMed ID: 19751200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The consequence of the chemical composition of HPMC in matrix tablets on the release behaviour of model drug substances having different solubility.
    Viridén A; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Jan; 77(1):99-110. PubMed ID: 21081160
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
    Javadzadeh Y; Jafari-Navimipour B; Nokhodchi A
    Int J Pharm; 2007 Aug; 341(1-2):26-34. PubMed ID: 17498898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative study of propranolol hydrochloride release from matrix tablets with KollidonSR or hydroxy propyl methyl cellulose.
    Sahoo J; Murthy PN; Biswal S; Sahoo SK; Mahapatra AK
    AAPS PharmSciTech; 2008; 9(2):577-82. PubMed ID: 18459050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hot tabletting of slow-release tramadol hydrochloride microcapsules with cores obtained via compaction.
    Sawicki W; Mazgalski J; Jakubowska I
    Drug Dev Ind Pharm; 2010 Feb; 36(2):209-17. PubMed ID: 20070185
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formulation and evaluation of gastroretentive controlled release tablets of alfuzosin hydrochloride.
    Rudraswamy-Math NR; Gupta VR
    Pak J Pharm Sci; 2015 Nov; 28(6):2147-52. PubMed ID: 26639508
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.
    Khan ZA; Tripathi R; Mishra B
    AAPS PharmSciTech; 2011 Dec; 12(4):1312-23. PubMed ID: 21969244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of 5-fluorouracil release from hydroxypropylmethylcellulose compression-coated tablets.
    Wu B; Shun N; Wei X; Wu W
    Pharm Dev Technol; 2007; 12(2):203-10. PubMed ID: 17510892
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of beta-cyclodextrin complexation on carbamazepine release from hydroxypropyl methylcellulose matrix tablets.
    Koester LS; Xavier CR; Mayorga P; Bassani VL
    Eur J Pharm Biopharm; 2003 Jan; 55(1):85-91. PubMed ID: 12551708
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet.
    Nagarwal RC; Ridhurkar DN; Pandit JK
    AAPS PharmSciTech; 2010 Mar; 11(1):294-303. PubMed ID: 20182827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.